SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    K. Takeda, Y. Yamaguchi, M. Hino, F. Kato, Potentiation of Acetylcholine-Mediated Facilitation of Inhibitory Synaptic Transmission by an Azaindolizione Derivative, ZSET1446 (ST101), in the Rat Hippocampus, Journal of Pharmacology and Experimental Therapeutics, 2016, 356, 2, 446

    CrossRef

  2. 2
    Chris Bladen, Steven W. McDaniel, Vinicius M. Gadotti, Ravil R. Petrov, N. Daniel Berger, Philippe Diaz, Gerald W. Zamponi, Characterization of Novel Cannabinoid Based T-Type Calcium Channel Blockers with Analgesic Effects, ACS Chemical Neuroscience, 2015, 6, 2, 277

    CrossRef

  3. 3
    Johanna G. Pasek, Xiaohan Wang, Roger J. Colbran, Differential CaMKII regulation by voltage-gated calcium channels in the striatum, Molecular and Cellular Neuroscience, 2015, 68, 234

    CrossRef

  4. 4
    Serge Gauthier, Susan Rountree, Barbara Finn, Barbra LaPlante, Eckard Weber, Tilman Oltersdorf, Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer’s Disease: A Randomized Phase 2 Study, Journal of Alzheimer's Disease, 2015, 48, 2, 473

    CrossRef

  5. 5
    Norbert Weiss, T-type Ca2+channels make your brain smarter, Channels, 2015, 9, 3, 115

    CrossRef

  6. 6
    Shreaya Chakroborty, Grace E. Stutzmann, Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures, European Journal of Pharmacology, 2014, 739, 83

    CrossRef

  7. 7
    Xiaona Du, Han Hao, Sylvain Gigout, Dongyang Huang, Yuehui Yang, Li Li, Caixue Wang, Danielle Sundt, David B. Jaffe, Hailin Zhang, Nikita Gamper, Control of somatic membrane potential in nociceptive neurons and its implications for peripheral nociceptive transmission, Pain, 2014, 155, 11, 2306

    CrossRef

  8. 8
    Y. Yabuki, Y. Ohizumi, A. Yokosuka, Y. Mimaki, K. Fukunaga, Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice, Neuroscience, 2014, 259, 126

    CrossRef

  9. 9
    Juan-Alberto Arranz-Tagarro, Cristóbal de los Ríos, Antonio G García, Juan-Fernando Padín, Recent patents on calcium channel blockers: emphasis on CNS diseases, Expert Opinion on Therapeutic Patents, 2014, 24, 9, 959

    CrossRef

  10. 10
    Juliane Proft, Norbert Weiss, T-type Ca2+channels, Communicative & Integrative Biology, 2014, 7, 2, e28424

    CrossRef

  11. 11
    Ana Sofía Vallés, María Virginia Borroni, Francisco J. Barrantes, Targeting Brain α7 Nicotinic Acetylcholine Receptors in Alzheimer’s Disease: Rationale and Current Status, CNS Drugs, 2014, 28, 11, 975

    CrossRef

  12. 12
    Liang Chen, Yanyan Miao, Lin Chen, Jing Xu, Xinxing Wang, Han Zhao, Yi Shen, Yi Hu, Yunpeng Bian, Yuanyuan Shen, Jutao Chen, Yingying Zha, Long-Ping Wen, Ming Wang, The role of low levels of fullerene C60 nanocrystals on enhanced learning and memory of rats through persistent CaMKII activation, Biomaterials, 2014, 35, 34, 9269

    CrossRef

  13. 13
    Yoshimasa Yamaguchi, Kentaro Takeda, Masataka Hino, Combination Effects of ZSET1446/ST101 With Memantine on Cognitive Function and Extracellular Acetylcholine in the Hippocampus, Journal of Pharmacological Sciences, 2013, 123, 4, 347

    CrossRef

  14. 14
    Yui Yamamoto, Norifumi Shioda, Feng Han, Shigeki Moriguchi, Kohji Fukunaga, The Novel Cognitive Enhancer ST101 Enhances Acetylcholine Release in Mouse Dorsal Hippocampus Through T-type Voltage-Gated Calcium Channel Stimulation, Journal of Pharmacological Sciences, 2013, 121, 3, 212

    CrossRef